Shanghai Yihao Biological Technology Co., Ltd, Shanghai, 200231, China.
Institute of Tumor of Nantong Tumor Hospital, No.30, North Tongyang Road, Pingchao Town, Tongzhou District, Nantong City, Jiangsu Province, 226361, China.
J Pharm Biomed Anal. 2021 May 10;198:114000. doi: 10.1016/j.jpba.2021.114000. Epub 2021 Mar 2.
Among the many systems available for heterologous protein production gram-negative bacterium Escherichia coli (E. coli) has long been widely used because of its ability to grow rapidly with a high density on inexpensive substrates. The use of E. coli as the host system has many regulatory issues, one of which is the residual host cell DNA. Residual DNA carried by biological products may lead to carcinogenicity and immunomodulation risks. The World Health Organization (WHO) for the acceptable amounts of residual host cell DNA is less than 10 ng per dose. Therefore, it is important to keep an extremely low level of residual host DNA in the biological products derived from E. coli. In this study, we designed primer/probe sets targeting E. coli 23S ribosomal RNA gene to quantify the residual DNA of E. coli by quantitative polymerase chain reactions (qPCR). Result showed that this primer/probe has high species specificity. The limit of detection (LOD) in this method is 0.01 pg/μl and this allowed for detection of residual host DNA of much lower concentrations. We assessed accuracy by calculating the recovery (92.1∼140.1 %) of the spiked DNA in plasmids which were produced from E. coli. We also checked intra-assay precision (9.8∼15.1 %) and inter-assay precision (10.9∼18.3 %) by repeatedly measuring the four different concentration standards. In addition, the robustness assay was performed by generating standard curve using short length E. coli DNA. The result showed that appropriate degree of DNA fragmentation will not affect tests. These validation studies demonstrated that our method has excellent specificity, linearity, accuracy, precision and robustness.
在众多可用于异源蛋白生产的系统中,革兰氏阴性菌大肠杆菌(E. coli)因其能够在廉价基质上快速高密度生长的能力而被长期广泛应用。将 E. coli 用作宿主系统存在许多监管问题,其中之一是残留的宿主细胞 DNA。生物制品中携带的残留 DNA 可能导致致癌性和免疫调节风险。世界卫生组织(WHO)规定可接受的残留宿主细胞 DNA 量为每剂小于 10ng。因此,在源自 E. coli 的生物制品中保持极低水平的残留宿主 DNA 非常重要。在本研究中,我们设计了针对大肠杆菌 23S 核糖体 RNA 基因的引物/探针组,通过实时聚合酶链反应(qPCR)定量检测大肠杆菌的残留 DNA。结果表明,该引物/探针具有很高的物种特异性。该方法的检测限(LOD)为 0.01pg/μl,可检测到更低浓度的残留宿主 DNA。我们通过计算质粒中掺入 DNA 的回收率(92.1∼140.1%)来评估准确性,这些质粒是由 E. coli 产生的。我们还通过反复测量四个不同浓度的标准品来检查批内精密度(9.8∼15.1%)和批间精密度(10.9∼18.3%)。此外,通过使用短长度的大肠杆菌 DNA 生成标准曲线来进行稳健性测试。结果表明,适当程度的 DNA 片段化不会影响测试。这些验证研究表明,我们的方法具有出色的特异性、线性、准确性、精密度和稳健性。